QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jonestrading-downgrades-concert-pharma-to-hold

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

 why-jupiter-wellness-shares-are-trading-lower-by-around-40-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointe...

 concert-pharmaceuticals-coeur-mining-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains i...

 dow-falls-200-points-jobless-claims-drop-to-4-month-low

U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.

 why-huadi-international-group-shares-dipped-around-91-here-are-79-biggest-movers-from-yesterday

Gainers

 concert-pharma-q3-earnings-insights

Concert Pharma (NASDAQ:CNCE) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investo...

 concert-pharmaceuticals-q3-eps-058-up-from-078-yoy-sales-800k-down-from-54300k-yoy

Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(0.58) per share. This is a 25.64 percent increase over los...

 earnings-scheduled-for-november-7-2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per...

 planet-labs-core--main-and-some-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gain...

 truist-securities-maintains-buy-on-concert-pharma-raises-price-target-to-25

Truist Securities analyst Joon Lee maintains Concert Pharma (NASDAQ:CNCE) with a Buy and raises the price target from $22 to...

 benzingas-top-ratings-upgrades-downgrades-for-august-25-2022

Upgrades

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION